Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hypertension treatment guidelines: is it time for an update?

Literature DB >> 17215653

Hypertension treatment guidelines: is it time for an update?

Marvin Moser.

Abstract

Entities: Chemical

Mesh：

Substances：
Antihypertensive Agents

Year: 2007 PMID： 17215653 PMCID： PMC8109860 DOI： 10.1111/j.1524-6175.2007.5998.x

Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN： 1524-6175 Impact factor: 3.738

× No keyword cloud information.

24 in total

Review 1. Clinical practice. Resistant or difficult-to-control hypertension.

Authors: Marvin Moser; John F Setaro
Journal: N Engl J Med Date: 2006-07-27 Impact factor: 91.245

2. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

Authors: F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin
Journal: N Engl J Med Date: 2001-01-04 Impact factor: 91.245

3. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.

Authors:
Journal: BMJ Date: 1998-09-12

4. Resistant hypertension: comparing hemodynamic management to specialist care.

Authors: Sandra J Taler; Stephen C Textor; Jo Ellen Augustine
Journal: Hypertension Date: 2002-05 Impact factor: 10.190

5. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study.

Authors: G Lindberg; K Bingefors; J Ranstam; L Råstam; A Melander
Journal: BMJ Date: 1998-03-07

6. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

Authors: B Williams; N R Poulter; M J Brown; M Davis; G T McInnes; J F Potter; P S Sever; S McG Thom
Journal: J Hum Hypertens Date: 2004-03 Impact factor: 3.012

7. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Authors: Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony Schork; Beverly Smith; Alberto Zanchetti
Journal: Lancet Date: 2004-06-19 Impact factor: 79.321

8. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal: JAMA Date: 2003-05-14 Impact factor: 56.272

Hypertension treatment guidelines: is it time for an update?

Review 1. Clinical practice. Resistant or difficult-to-control hypertension.

2. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

3. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.

4. Resistant hypertension: comparing hemodynamic management to specialist care.

5. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study.

6. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

7. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

8. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

9. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.

10. The ASCOT Trial--are beta-blockers still useful as antihypertensive medication?

Review 1. Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look.

Review 2. Current and future status of beta-blockers in the treatment of hypertension.

3. HNF4alpha dysfunction as a molecular rational for cyclosporine induced hypertension.